Location: | London, Hybrid |
---|---|
Salary: | £45,700 to £55,240 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 5th March 2025 |
---|---|
Closes: | 27th March 2025 |
Job Ref: | MED05111 |
Location: South Kensington Campus - Hybrid
About the role:
We are looking for a Clinical Trial Coordinator to join our team.
The Cancer Clinical Trials Section (CCTS) / Imperial Clinical Trials Unit-Cancer (ICTU-Ca), led by Professor Michael Seckl through its close association with the Imperial Clinical Trials Unit and Imperial Experimental Cancer Medicine Centre, provides a core accredited environment to develop and conduct world-class cancer clinical trials. With a major focus on precision medicine and proof of concept clinical trials, CCTS / ICTU-Ca currently undertakes studies in the phase Ib to phase III space across multiple sites of disease, both nationally and internationally. The cancer trial portfolio utilises the research expertise in our department to enable trials that include new and exciting imaging modalities, translational research initiatives and innovative study designs as they evolve.
ICTU-Ca forms part of the Imperial Clinical Trials Unit (ICTU). Cancer is just one of several therapeutic areas including cardiovascular and metabolic disease, respiratory, HIV / infectious diseases, surgery and emergency and critical care. These disciplines all come together under the overarching, UKCRC registered ICTU.
What you would be doing:
What we are looking for:
What we can offer you:
Further Information
This role is full-time and fixed term until 31st March 2027 in the first instance based at South Kensington Campus.
You will need to complete an online application.
If you require any further details about the role, please contact:
Mr Lee Webber – lee.webber@imperial.ac.uk
Type / Role:
Subject Area(s):
Location(s):